Investor Relations
Investor Relations Contact:
LHA
Anne Marie Fields
212-838-3777
afields@lhai.com
or
Bruce Voss
310-691-7100
bvoss@lhai.com

Media Contact
Rooney & Associates
Terry Rooney
212-223-0689
trooney@rooneyco.com
or
Marion Janic
212-223-4017
mjanic@rooneyco.com

Press Releases

All Releases
View Summary OPKO Receives Complete Response Letter from FDA for RAYALDEE® New Drug Application
Mar 30, 2016
PDF 20.8 KB
View Summary OPKO Health Announces Executive Appointment
Mar 28, 2016
PDF 14.1 KB
View Summary OPKO To Present 18-24 Month Clinical Data on its Long-acting Human Growth Hormone (hGH-CTP) from Open Label Extension (OLE) Phase 2 Pediatric Growth Hormone Deficiency Clinical Study in Oral Presentation at ENDO 2016
Mar 24, 2016
PDF 22.4 KB
View Summary OPKO Health Announces Dosing of First Subject in Phase 1 Clinical Study of a Long-Acting Oxyntomodulin for the Treatment of Obesity and Type II Diabetes
Mar 16, 2016
PDF 13.7 KB
View Summary OPKO 4Kscore® Recommended in 2016 European Association of Urology Prostate Cancer Guidelines
Mar 15, 2016
PDF 14.9 KB
View Summary OPKO Health Names Dr. Gregory Henderson President of Bio-Reference Laboratories
Mar 15, 2016
PDF 17.2 KB
View Summary OPKO Health to Present at the 2016 Barclays Global Healthcare Conference
Mar 7, 2016
PDF 11.6 KB
View Summary OPKO's GeneDx Presenting on a Number of Topics at the 2016 ACMG Annual Clinical Genetics Meeting
Mar 2, 2016
PDF 16.8 KB
View Summary OPKO Announces Financial and Operating Results
Feb 29, 2016
PDF 33.0 KB
View Summary OPKO's GeneDx Participating in the Molecular Medicine Tri-Conference 2016 in San Francisco
Feb 24, 2016
PDF 16.1 KB
View Summary OPKO Health Announces Dosing of First Patient in Phase 2a Clinical Study of a Long-Acting Factor VIIa for the Treatment of Hemophilia
Feb 23, 2016
PDF 15.1 KB
View Summary OPKO to Announce 2015 Fourth Quarter and Full Year Financial Results on February 29, 2016
Feb 23, 2016
PDF 13.1 KB
View Summary OPKO Health to Present at the RBC Capital Markets Global Healthcare Conference
Feb 18, 2016
PDF 11.7 KB
View Summary Study Demonstrates OPKO's 4Kscore Test Reduces Unnecessary Prostate Biopsies While Improving Risk Prediction for Aggressive Prostate Cancer
Feb 9, 2016
PDF 67.5 KB
View Summary OPKO's GeneDx to Present at Personalized Medicine World Conference
Jan 22, 2016
PDF 15.7 KB
View Summary OPKO Health to Present at the J.P. Morgan 34th Annual Healthcare Conference
Jan 6, 2016
PDF 11.6 KB
View Summary Conversion Right Extended on OPKO 3.0% Convertible Senior Notes
Jan 5, 2016
PDF 11.5 KB
View Summary OPKO's GeneDx Study of More Than 10,000 Individuals Tested with Multigene NGS Hereditary Cancer Panel Reveals New Risks
Dec 21, 2015
PDF 15.9 KB
View Summary OPKO's GeneDx Subsidiary and North Shore-LIJ Health System Form Strategic Alliance for Genetic Testing
Dec 14, 2015
PDF 20.4 KB
View Summary OPKO's GeneDx Study Demonstrates Whole Exome Sequencing Usefulness In Diagnosing Rare Disorders
Dec 9, 2015
PDF 13.1 KB
Showing 61-80 of 331 Page: 1 2 3 4 5 6 7 8 ... 17  Previous 20 | Next 20

Email  Sign up for email alerts